EcoDrugPlus

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSOSIG00000003313
Gene Symbol: TGFBR1B
1 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSOSIG00000014257
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSOSIG00000012093
Gene Symbol: TPH1A
1 Cross references
207 Possible Orthologues:

Tryptophan Hydroxylase 1b

Ensembl ID : ENSOSIG00000005044
Gene Symbol: TPH1B
1 Cross references
176 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSOSIG00000023736
Gene Symbol: TUBA4A
1 Cross references
170 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSOSIG00000016140
Gene Symbol: TUBB2
1 Cross references
305 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOSIG00000009318
Gene Symbol: TYR
1 Cross references
197 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOSIG00000002908
Gene Symbol: TYR
1 Cross references
201 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOSIG00000012230
Gene Symbol: TYR
1 Cross references
201 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOSIG00000007692
Gene Symbol: TYK2
1 Cross references
195 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSOSIG00000004645
Gene Symbol: UTS2R
1 Cross references
97 Possible Orthologues:

Utrophin

Ensembl ID : ENSOSIG00000020328
Gene Symbol: UTRN
1 Cross references
48 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).